Single Use Aspiration Needle NA NA-401D-1521Recalls & reported problems
Olympus Medical Systems Corp. · Class 1
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 04953170196683), received between Jun 22, 2022 and Aug 15, 2025 — classified as 2 injuries, 2 malfunctions.
The most frequently reported specific device problem is “Material Puncture/Hole” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem2
- Material Puncture/Hole2
Patient problems
- No Clinical Signs, Symptoms or Conditions2
- Pneumothorax2
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
MalfunctionAug 15, 2025Material Puncture/Hole; Material Puncture/Hole
IT WAS REPORTED THE ASPIRATION NEEDLE PIERCED THE METAL SHEATH. THE ISSUE OCCURRED DURING A DIAGNOSTIC BRONCHOSCOPY PROCEDURE THAT WAS COMPLETED WITH A SIMILAR DEVICE. THERE WERE NO REPORTS OF PATIENT HARM.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22817063 ↗InjuryJul 21, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
OLYMPUS REVIEW THE FOLLOWING LITERATURE TITLED "VALUE OF DIFFERENT BRONCHOSCOPIC SAMPLING TECHNIQUES IN DIAGNOSIS OF SARCOIDOSIS: A PROSPECTIVE STUDY OF 151 PATIENTS". LITERATURE SUMMARY: THIS PROSPECTIVE STUDY DESCRIBES THE VALUE OF DIFFERENT BRONCHOSCOPIC SAMPLING TECHNIQUES IN DIAGNOSIS OF SARCOIDOSIS. OF THE 164 PATIENTS STUDIED, 151 WERE FINALLY DIAGNOSED AS SARCOIDOSIS. GRANULOMAS WERE DEMONSTRATED IN 127 (84.2%) PATIENTS. THE PROCEDURE WAS PERFORMED IN THE SUPINE POSITION BY TRANS NASAL (OR ORAL) ROUTE BY EXPERIENCED FACULTY OR BY FELLOWS UNDER DIRECT SUPERVISION, USING A FIBEROPTIC BRONCHOSCOPE (BF-1T20 OR BF-TE2; OLYMPUS, JAPAN; FB 19TV; PENTAX, JAPAN). EBB (AT LEAST 4 SPECIMENS) WAS PERFORMED WITH THE STANDARD BIOPSY FORCEPS (FB15C; OLYMPUS) FROM THE ABNORMAL LOOKING AREAS IF ANY; OR FROM SECONDARY CARINAL AREAS. TRANSBRONCHIAL LUNG BIOPSIES (AT LEAST 4 SPECIMENS) WERE OBTAINED WITHOUT FLUOROSCOPY USING THE STANDARD BIOPSY FORCEPS (FB19C; OLYMPUS) FROM THE SITE OF MAXIMAL INVOLVEMENT ON CT CHEST OR FROM RIGHT LOWER LOBE, IF CT CHEST WAS NORMAL. THREE PASSES WERE ATTEMPTED IN EACH LYMPH NODE STATION USING THE CONVENTIONAL 21 G TBNA NEEDLE (SMOOTH SHOT; OLYMPUS) WITHOUT AN
Patient problems: Pneumothorax
MAUDE report 15074969 ↗InjuryJul 19, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
OLYMPUS REVIEWED THE FOLLOWING LITERATURE TITLED, "CONVENTIONAL TRANSBRONCHIAL NEEDLE ASPIRATION VERSUS ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION, WITH OR WITHOUT RAPID ON-SITE EVALUATION, FOR THE DIAGNOSIS OF SARCOIDOSIS: A RANDOMIZED CONTROLLED TRIAL." LITERATURE SUMMARY: THIS STUDY DESCRIBES ABOUT CONVENTIONAL TRANSBRONCHIAL NEEDLE ASPIRATION VERSUS ENDOBRONCHIAL ULTRASOUND¿GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION, WITH OR WITHOUT RAPID ON-SITE EVALUATION, FOR THE DIAGNOSIS OF SARCOIDOSIS. EIGHTY PATIENTS WITH SUSPECTED SARCOIDOSIS WERE RANDOMIZED 1:1:1:1 INTO 4 GROUPS: C-TBNA WITH OUT ROSE (TBNA-NR), C-TBNA WITH ROSE (TBNA-R), EBUS-TBNA WITHOUT ROSE (EBUS NR), AND EBUS-TBNA WITH ROSE (EBUS-R). EBB AND TBLB WERE PERFORMED IN ALL PATIENTS. FLEXIBLE BRONCHOSCOPY WAS PERFORMED THROUGH THE NASAL/ORAL ROUTE USING THE OLYMPUS BF-TE2 FIBEROPTIC BRONCHOSCOPE/OLYMPUS 1T180 VIDEO BRONCHOSCOPE. C-TBNA WAS PERFORMED FROM THE SUBCARINAL (STATION 7) AND/OR LOWER RIGHT PARATRACHEAL (4R) STATIONS USING THE 21-G TBNA NEEDLE (SMOOTH SHOT NA-401D-1521; OLYMPUS). EBUS-TBNA WAS PERFORMED THROUGH THE ORAL ROUTE UNDER MODERATE SEDATION AFTER INSERTION OF A BITE BLOCK, USING THE E
Patient problems: Pneumothorax
MAUDE report 15053140 ↗MalfunctionJun 22, 2022Material Puncture/Hole; Material Puncture/Hole
THE PROCEDURE BEING PERFORMED WE AS A BRONCHOSCOPY. THERE WAS A 5 MINUTE DELAY IN THE PROCEDURE DUE TO THE DEVICE ISSUE. THE PROCEDURE WAS COMPLETED WITH WASHINGS INSTEAD TO CONFIRM CANCER DIAGNOSIS. THE CUSTOMER HOPES THIS IS AS RELEVANT AS AN ASPIRATION. THE PATIENT'S CURRENT CONDITION IS REPORTED AS "UNSURE".
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 14772452 ↗
Other NEEDLE, ASPIRATION AND INJECTION, DISPOSABLE devices
- N/A 305211Becton, Dickinson And Company · NEEDLE, ASPIRATION AND INJECTION, DISPOSABLE425 reports
- N/A 305180Becton, Dickinson And Company · NEEDLE, ASPIRATION AND INJECTION, DISPOSABLE300 reports
- N/A 305200Becton, Dickinson And Company · NEEDLE, ASPIRATION AND INJECTION, DISPOSABLE99 reports
- PneumoDart TM-317TyTek Medical Inc. · Needle, Aspiration And Injection, Disposable1 recall1 report
- TPAK TM-303TyTek Medical Inc. · Needle, Aspiration And Injection, Disposable1 recall0 reports
- N/A 305181Becton, Dickinson And Company · NEEDLE, ASPIRATION AND INJECTION, DISPOSABLE32 reports
- SOL-M™ Blunt Fill Needle with 5 Micron Filter 110022Sol-Millennium Medical, Inc. · Needle, Aspiration And Injection, Disposable17 reports
- CONFIDENCE SPINAL CEMENT SYSTEM 283903611Medos International Sàrl · NEEDLE, ASPIRATION AND INJECTION, DISPOSABLE17 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page